vs

RHYTHM PHARMACEUTICALS, INC.(RYTM)与Velocity Financial, Inc.(VEL)财务数据对比。点击上方公司名可切换其他公司

RHYTHM PHARMACEUTICALS, INC.的季度营收约是Velocity Financial, Inc.的1.1倍($57.3M vs $51.6M),Velocity Financial, Inc.净利率更高(67.3% vs -83.0%,领先150.3%),RHYTHM PHARMACEUTICALS, INC.同比增速更快(36.9% vs 32.8%),过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高(48.5% vs 32.3%)

Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业,主要开发和商业化针对罕见遗传性肥胖症的靶向疗法,覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症,服务北美、欧洲地区缺少有效治疗方案的患者群体。

Velocity Financial, Inc.是一家总部位于美国的房地产金融企业,主要面向住宅投资物业提供专业化抵押贷款解决方案,与全美独立抵押贷款经纪人合作,为房地产投资者提供定制化的短期过桥贷款及长期租赁物业融资产品。

RYTM vs VEL — 直观对比

营收规模更大
RYTM
RYTM
是对方的1.1倍
RYTM
$57.3M
$51.6M
VEL
营收增速更快
RYTM
RYTM
高出4.1%
RYTM
36.9%
32.8%
VEL
净利率更高
VEL
VEL
高出150.3%
VEL
67.3%
-83.0%
RYTM
两年增速更快
RYTM
RYTM
近两年复合增速
RYTM
48.5%
32.3%
VEL

损益表 — Q4 FY2025 vs Q4 FY2025

指标
RYTM
RYTM
VEL
VEL
营收
$57.3M
$51.6M
净利润
$-47.5M
$34.8M
毛利率
91.6%
营业利润率
-82.2%
97.0%
净利率
-83.0%
67.3%
营收同比
36.9%
32.8%
净利润同比
-9.6%
67.0%
每股收益(稀释后)
$-0.73
$0.90

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
RYTM
RYTM
VEL
VEL
Q4 25
$57.3M
$51.6M
Q3 25
$51.3M
$49.1M
Q2 25
$48.5M
$47.6M
Q1 25
$32.7M
$37.5M
Q4 24
$41.8M
$38.9M
Q3 24
$33.3M
$35.1M
Q2 24
$29.1M
$32.4M
Q1 24
$26.0M
$29.5M
净利润
RYTM
RYTM
VEL
VEL
Q4 25
$-47.5M
$34.8M
Q3 25
$-52.9M
$25.4M
Q2 25
$-46.6M
$26.0M
Q1 25
$-49.5M
$18.9M
Q4 24
$-43.3M
$20.8M
Q3 24
$-43.6M
$15.8M
Q2 24
$-32.3M
$14.8M
Q1 24
$-141.4M
$17.3M
毛利率
RYTM
RYTM
VEL
VEL
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
营业利润率
RYTM
RYTM
VEL
VEL
Q4 25
-82.2%
97.0%
Q3 25
-102.6%
72.1%
Q2 25
-93.4%
71.3%
Q1 25
-143.7%
71.7%
Q4 24
-98.6%
82.5%
Q3 24
-132.0%
60.6%
Q2 24
-139.2%
61.3%
Q1 24
-538.7%
78.8%
净利率
RYTM
RYTM
VEL
VEL
Q4 25
-83.0%
67.3%
Q3 25
-103.1%
51.7%
Q2 25
-96.1%
54.6%
Q1 25
-151.4%
50.4%
Q4 24
-103.6%
53.5%
Q3 24
-131.2%
45.1%
Q2 24
-110.9%
45.6%
Q1 24
-544.4%
58.5%
每股收益(稀释后)
RYTM
RYTM
VEL
VEL
Q4 25
$-0.73
$0.90
Q3 25
$-0.82
$0.65
Q2 25
$-0.75
$0.69
Q1 25
$-0.81
$0.51
Q4 24
$-0.71
$0.56
Q3 24
$-0.73
$0.44
Q2 24
$-0.55
$0.42
Q1 24
$-2.35
$0.49

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
RYTM
RYTM
VEL
VEL
现金及短期投资手头流动性
$388.9M
$92.1M
总债务越低越好
股东权益账面价值
$139.1M
$672.5M
总资产
$480.2M
$7.4B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
RYTM
RYTM
VEL
VEL
Q4 25
$388.9M
$92.1M
Q3 25
$416.1M
$99.0M
Q2 25
$291.0M
$79.6M
Q1 25
$314.5M
$51.7M
Q4 24
$320.6M
$49.9M
Q3 24
$298.4M
$44.1M
Q2 24
$319.1M
$47.4M
Q1 24
$201.2M
$34.8M
股东权益
RYTM
RYTM
VEL
VEL
Q4 25
$139.1M
$672.5M
Q3 25
$148.8M
$634.3M
Q2 25
$-11.9M
$597.9M
Q1 25
$18.9M
$563.2M
Q4 24
$21.7M
$516.9M
Q3 24
$11.2M
$484.6M
Q2 24
$39.3M
$471.3M
Q1 24
$61.6M
$452.9M
总资产
RYTM
RYTM
VEL
VEL
Q4 25
$480.2M
$7.4B
Q3 25
$506.9M
$7.0B
Q2 25
$372.7M
$6.5B
Q1 25
$386.7M
$6.0B
Q4 24
$392.3M
$5.5B
Q3 24
$363.6M
$5.2B
Q2 24
$381.8M
$4.9B
Q1 24
$258.7M
$4.6B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
RYTM
RYTM
VEL
VEL
经营现金流最新季度
$-25.4M
$18.2M
自由现金流经营现金流 - 资本支出
$17.9M
自由现金流率自由现金流/营收
34.6%
资本支出强度资本支出/营收
0.5%
现金转化率经营现金流/净利润
0.52×
过去12个月自由现金流最近4个季度
$40.3M

8季度趋势,按日历期对齐

经营现金流
RYTM
RYTM
VEL
VEL
Q4 25
$-25.4M
$18.2M
Q3 25
$-26.6M
$11.5M
Q2 25
$-23.3M
$7.7M
Q1 25
$-40.4M
$3.5M
Q4 24
$-18.8M
$37.8M
Q3 24
$-25.2M
$-17.6M
Q2 24
$-29.1M
$11.5M
Q1 24
$-40.7M
$10.6M
自由现金流
RYTM
RYTM
VEL
VEL
Q4 25
$17.9M
Q3 25
$11.4M
Q2 25
$7.6M
Q1 25
$3.5M
Q4 24
$37.5M
Q3 24
$-17.6M
Q2 24
$11.4M
Q1 24
$10.5M
自由现金流率
RYTM
RYTM
VEL
VEL
Q4 25
34.6%
Q3 25
23.2%
Q2 25
15.9%
Q1 25
9.2%
Q4 24
96.4%
Q3 24
-50.3%
Q2 24
35.1%
Q1 24
35.8%
资本支出强度
RYTM
RYTM
VEL
VEL
Q4 25
0.5%
Q3 25
0.1%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
0.7%
Q3 24
0.2%
Q2 24
0.3%
Q1 24
0.1%
现金转化率
RYTM
RYTM
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
1.81×
Q3 24
-1.11×
Q2 24
0.78×
Q1 24
0.61×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

RYTM
RYTM

暂无分部数据

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

相关对比